These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20964573)

  • 1. Chronic urticaria and irregular menstrual cycle: a case report of effective therapy with oral contraception.
    Kasperska-Zając A; Zamlynski J
    J Dermatolog Treat; 2012 Apr; 23(2):159-60. PubMed ID: 20964573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillophlebitis associated with the use of oral contraceptive: a case report.
    Eski Yücel O; Güngor I; Gül A; Turgut M; Aritürk N
    Gynecol Endocrinol; 2015; 31(8):601-3. PubMed ID: 26291803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic trend in acne associated with the menstrual cycle].
    Cersosimo L; Iannucci D; Consalvo F; Orgiu G
    Clin Ter; 1983 Jun; 105(5):411-4. PubMed ID: 6223780
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocervical metaplasia of the endometrium in a patient with cystic fibrosis: a case report.
    Piccoli R; Di Spiezio Sardo A; Insabato L; Acunzo G; Guida M; Nappi C
    Fertil Steril; 2006 Mar; 85(3):750.e13-750.e16. PubMed ID: 16500350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The menstrual cycle after oral contraceptives].
    Hauser GA; Girotti M
    Geburtshilfe Frauenheilkd; 1967 Jun; 27(6):626-30. PubMed ID: 5592760
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptive pill use and abnormal menstrual cycles in women with severe condylar resorption: a case for low serum 17beta-estradiol as a major factor in progressive condylar resorption.
    Gunson MJ; Arnett GW; Formby B; Falzone C; Mathur R; Alexander C
    Am J Orthod Dentofacial Orthop; 2009 Dec; 136(6):772-9. PubMed ID: 19962599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
    Gul OB; Somunkiran A; Yucel O; Demirci F; Ozdemir I
    Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.
    Naka KK; Kalantaridou SN; Bechlioulis A; Kravariti M; Kazakos N; Katsouras CS; Tsatsoulis A; Michalis LK
    Gynecol Endocrinol; 2011 Sep; 27(9):615-21. PubMed ID: 21329419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Choosing contraception for adolescents].
    Wemeau-jacquemont C
    NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some aspects of studies with oral contraceptives in Indian women.
    Shah PN
    J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic uses of contraceptive steroids.
    Starks GC
    J Fam Pract; 1984 Sep; 19(3):315-21. PubMed ID: 6470632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
    Henrion R; Laveissiere MN
    Contracept Fertil Sex (Paris); 1982 Oct; 10(10):653-7. PubMed ID: 12338447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R; Herer P; Shen-Orr Z
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pills and minipills].
    Koffel JC
    Bull Soc Pharm Strasb; 1978; 21(1):43-53. PubMed ID: 12261367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.